Page last updated: 2024-11-02

oxidopamine and Herpes Simplex Keratitis

oxidopamine has been researched along with Herpes Simplex Keratitis in 1 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Templeton, A1
Nguyen, G1
Ash, JD1
Straub, RH1
Carr, DJ1

Other Studies

1 other study available for oxidopamine and Herpes Simplex Keratitis

ArticleYear
Chemical sympathectomy increases susceptibility to ocular herpes simplex virus type 1 infection.
    Journal of neuroimmunology, 2008, Jun-15, Volume: 197, Issue:1

    Topics: Animals; Brain Stem; Cell Line, Tumor; Cornea; Disease Susceptibility; Female; Herpesvirus 1, Human;

2008